-
1
-
-
42249101037
-
The history of cytomegalovirus and its diseases
-
HoM
-
HoM, 2008. The history of cytomegalovirus and its diseases. Med. Microbiol. Immunol. 197:65-73. http://dx.doi.org/10.1007/s00430-007-0066-x.
-
(2008)
Med. Microbiol. Immunol.
, vol.197
, pp. 65-73
-
-
-
2
-
-
0038362228
-
The human cytomegalovirus
-
DOI 10.1016/S0163-7258(03)00034-2
-
Landolfo S, Gariglio M, Gribaudo G, Lembo D. 2003. The human cytomegalovirus. Pharmacol. Ther. 98:269-297. http://dx.doi.org/10.1016/S0163- 7258(03)00034-2. (Pubitemid 36638545)
-
(2003)
Pharmacology and Therapeutics
, vol.98
, Issue.3
, pp. 269-297
-
-
Landolfo, S.1
Gariglio, M.2
Gribaudo, G.3
Lembo, D.4
-
3
-
-
0032623289
-
Regulation of human cytomegalovirus gene expression
-
Fortunato EA, Spector DH. 1999. Regulation of human cytomegalovirus gene expression. Adv. Virus Res. 54:61-128. http://dx.doi.org/10.1016/S0065-3527(08) 60366-8.
-
(1999)
Adv. Virus Res.
, vol.54
, pp. 61-128
-
-
Fortunato, E.A.1
Spector, D.H.2
-
4
-
-
84872172828
-
The "silent" global burden of congenital cytomegalovirus
-
Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. 2013. The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 26:86-102. http://dx.doi.org/10.1128/CMR.00062-12.
-
(2013)
Clin. Microbiol. Rev.
, vol.26
, pp. 86-102
-
-
Manicklal, S.1
Emery, V.C.2
Lazzarotto, T.3
Boppana, S.B.4
Gupta, R.K.5
-
6
-
-
33747141729
-
Antiviral drugs for cytomegalovirus diseases
-
DOI 10.1016/j.antiviral.2006.05.002, PII S016635420600129X
-
Biron KK. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Res. 71:154-163. http://dx.doi.org/10.1016/j.antiviral.2006.05.002. (Pubitemid 44223768)
-
(2006)
Antiviral Research
, vol.71
, Issue.2-3 SPEC. ISS.
, pp. 154-163
-
-
Biron, K.K.1
-
7
-
-
0036014080
-
Valganciclovir: An advance in cytomegalovirus therapeutics
-
Cocohoba JM, McNickoll IR. 2002. Valganciclovir: an advance in cytomegalovirus therapeutics. Ann. Pharmacother. 36:1075-1079. http://dx.doi.org/10.1345/aph.1A393. (Pubitemid 34564394)
-
(2002)
Annals of Pharmacotherapy
, vol.36
, Issue.6
, pp. 1075-1079
-
-
Cocohoba, J.M.1
McNicholl, I.R.2
-
8
-
-
0344938363
-
Antiviral drugs
-
Balfour HH. 1999. Antiviral drugs. N. Engl. J. Med. 340:1255-1268. http://dx.doi.org/10.1056/NEJM199904223401608.
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 1255-1268
-
-
Balfour, H.H.1
-
9
-
-
2542418810
-
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs
-
DOI 10.1016/j.humimm.2004.02.007, PII S0198885904000436
-
Baldanti F, Lurain N, Gerna G. 2004. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum. Immunol. 65:403-409. http://dx.doi.org/10.1016/j.humimm.2004.02.007. (Pubitemid 38686763)
-
(2004)
Human Immunology
, vol.65
, Issue.5
, pp. 403-409
-
-
Baldanti, F.1
Lurain, N.2
Gerna, G.3
-
10
-
-
0038574429
-
Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus
-
DOI 10.1086/375743
-
Chou S, Lurain NS, Thompson KD, Miner RC, Drew WL. 2003. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J. Infect. Dis. 188:32-39. http://dx.doi.org/10.1086/375743. (Pubitemid 36829739)
-
(2003)
Journal of Infectious Diseases
, vol.188
, Issue.1
, pp. 32-39
-
-
Chou, S.1
Lurain, N.S.2
Thompson, K.D.3
Miner, R.C.4
Drew, W.L.5
-
11
-
-
0032890689
-
Resistance of human cytomegalovirus to antiviral drugs
-
Erice A. 1999. Resistance of human cytomegalovirus to antiviral drugs. Clin. Microbiol. Rev. 12:286-297. (Pubitemid 29196854)
-
(1999)
Clinical Microbiology Reviews
, vol.12
, Issue.2
, pp. 286-297
-
-
Erice, A.1
-
12
-
-
0028316163
-
Adverse effects and drug interactions of clinical importance with antiviral drugs
-
Morris DJ. 1994. Adverse effects and drug interactions of clinical importance with antiviral drugs. Drug Saf. 10:281-291. http://dx.doi.org/10. 2165/00002018-199410040-00002. (Pubitemid 24126220)
-
(1994)
Drug Safety
, vol.10
, Issue.4
, pp. 281-291
-
-
Morris, D.J.1
-
13
-
-
1642458720
-
Synthesis and Antiviral Activity of (Z)- and (E)-2,2-[Bis(hydroxymethyl) cyclopropylidene]methylpurines and -pyrimidines: Second-Generation Methylenecyclopropane Analogues of Nucleosides
-
DOI 10.1021/jm030316s
-
Zhou S, Breitenbach JM, Borysko KZ, Drach JC, Kern ER, Gullen E, Cheng YC, Zemlicka J. 2004. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides. J. Med. Chem. 47:566-575. http://dx.doi.org/10.1021/jm030316s. (Pubitemid 38129715)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.3
, pp. 566-575
-
-
Zhou, S.1
Breitenbach, J.M.2
Borysko, K.Z.3
Drach, J.C.4
Kern, E.R.5
Gullen, E.6
Cheng, Y.-C.7
Zemlicka, J.8
-
14
-
-
14744273965
-
In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication
-
DOI 10.1128/AAC.49.3.1039-1045.2005
-
Kern ER, Kushner NL, Hartline CB, Williams-Aziz SL, Harden EA, Zhou S, Zemlicka J, Prichard MN. 2005. In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication. Antimicrob. Agents Chemother. 49:1039-1045. http://dx.doi.org/10.1128/AAC.49.3. 1039-1045.2005. (Pubitemid 40327721)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.3
, pp. 1039-1045
-
-
Kern, E.R.1
Kushner, N.L.2
Hartline, C.B.3
Williams-Aziz, S.L.4
Harden, E.A.5
Zhou, S.6
Zemlicka, J.7
Prichard, M.N.8
-
15
-
-
9644281600
-
Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections
-
DOI 10.1128/AAC.48.12.4745-4753.2004
-
Kern ER, Bidanset DJ, Harline CB, Yan Z, Zemlicka J, Quenelle DC. 2004. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. Antimicrob. Agents Chemother. 48:4745-4753. http://dx.doi.org/10.1128/AAC.48.12.4745-4753.2004. (Pubitemid 39577680)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.12
, pp. 4745-4753
-
-
Kern, E.R.1
Bidanset, D.J.2
Hartline, C.B.3
Yan, Z.4
Zemlicka, J.5
Quenelle, D.C.6
-
16
-
-
75149130666
-
Preclinical pharmacokinetic, toxicokinetic and toxicology results for cyclopropavir, a promising new agent for the treatment of beta- and gamma-herpesviruses
-
Bowlin TL, Brooks JL, Zemlicka J. 2009. Preclinical pharmacokinetic, toxicokinetic and toxicology results for cyclopropavir, a promising new agent for the treatment of beta- and gamma-herpesviruses. Antiviral Res. 82:A46-A47. http://dx.doi.org/10.1016/j.antiviral.2009.02.104.
-
(2009)
Antiviral Res.
, vol.82
-
-
Bowlin, T.L.1
Brooks, J.L.2
Zemlicka, J.3
-
17
-
-
77955359554
-
Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir
-
Gentry BG, Kamil JP, Coen DM, Zemlicka J, Drach JC. 2010. Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir. Antimicrob. Agents Chemother. 54:3093-3098. http://dx.doi.org/10. 1128/AAC.00468-10.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 3093-3098
-
-
Gentry, B.G.1
Kamil, J.P.2
Coen, D.M.3
Zemlicka, J.4
Drach, J.C.5
-
18
-
-
84882322059
-
Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97
-
Gentry BG, Vollmer LE, Hall ED, Borysko KZ, Zemlicka J, Kamil JP, Drach JC. 2013. Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97. Antimicrob. Agents Chemother. 57:4343-4348. http://dx.doi.org/10.1128/AAC.00214-13.
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 4343-4348
-
-
Gentry, B.G.1
Vollmer, L.E.2
Hall, E.D.3
Borysko, K.Z.4
Zemlicka, J.5
Kamil, J.P.6
Drach, J.C.7
-
19
-
-
78650664958
-
Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility
-
Chou S, Bowlin TL. 2011. Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. Antimicrob. Agents Chemother. 55:382-384. http://dx.doi.org/10.1128/AAC.01259-10.
-
(2011)
Antimicrob. Agents Chemother.
, vol.55
, pp. 382-384
-
-
Chou, S.1
Bowlin, T.L.2
-
20
-
-
78549278033
-
Phosphorylation of antiviral and endogenous nucleotides to di- And triphosphates by guanosine monophosphate kinase
-
Gentry BG, Gentry SN, Jackson TL, Zemlicka J, Drach JC. 2011. Phosphorylation of antiviral and endogenous nucleotides to di- and triphosphates by guanosine monophosphate kinase. Biochem. Pharmacol. 81:43-49. http://dx.doi.org/10.1016/j.bcp.2010.09.005.
-
(2011)
Biochem. Pharmacol.
, vol.81
, pp. 43-49
-
-
Gentry, B.G.1
Gentry, S.N.2
Jackson, T.L.3
Zemlicka, J.4
Drach, J.C.5
-
21
-
-
84455169993
-
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure
-
Chou S, Marousek G, Bowlin TL. 2012. Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure. Antimicrob. Agents Chemother. 56:197-201. http://dx.doi.org/10.1128/AAC.05559- 11.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 197-201
-
-
Chou, S.1
Marousek, G.2
Bowlin, T.L.3
-
22
-
-
75149170079
-
Synthesis and enantioselectivity of cyclopropavir phosphates for cellular GMP kinase
-
Li C, Gentry BG, Drach JC, Zemlicka J. 2009. Synthesis and enantioselectivity of cyclopropavir phosphates for cellular GMP kinase. Nucleosides Nucleotides Nucleic Acids 28:795-808. http://dx.doi.org/10.1080/ 15257770903172720.
-
(2009)
Nucleosides Nucleotides Nucleic Acids
, vol.28
, pp. 795-808
-
-
Li, C.1
Gentry, B.G.2
Drach, J.C.3
Zemlicka, J.4
-
23
-
-
0014440753
-
Evaluation of 4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid (HEPES) as a tissue culture buffer
-
Shipman C, Jr. 1969. Evaluation of 4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid (HEPES) as a tissue culture buffer. Proc. Soc. Exp. Biol. Med. 130:305-310. http://dx.doi.org/10.3181/00379727-130-33543.
-
(1969)
Proc. Soc. Exp. Biol. Med.
, vol.130
, pp. 305-310
-
-
Shipman Jr., C.1
-
24
-
-
0021807545
-
Metabolic activation of the nucleoside analog 9-{[2-hydroxy-1- (hydroxymethyl)ethoxy]methyl}guanine in human diploid fibroblasts infected with human cytomegalovirus
-
DOI 10.1073/pnas.82.8.2473
-
Biron KK, Stanat SC, Sorrell JB, Fyfe JA, Keller PM, Lambe CU, Nelson DJ. 1985. Metabolic activation of the nucleoside analog 9-[(2-hydroxy-1- (hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 82:2473-2477. http://dx.doi.org/10.1073/pnas.82.8.2473. (Pubitemid 15071291)
-
(1985)
Proceedings of the National Academy of Sciences of the United States of America
, vol.82
, Issue.8
, pp. 2473-2477
-
-
Biron, K.K.1
Stanat, S.C.2
Sorrell, J.B.3
-
25
-
-
21744448680
-
GCV phosphates are transferred between HeLa cells despite lack of bystander cytotoxicity
-
DOI 10.1038/sj.gt.3302487
-
Gentry BG, Im M, Boucher PD, Ruch RJ, Shewach DS. 2005. GCV phosphates are transferred between HeLa cells despite lack of bystander cytotoxicity. Gene Ther. 12:1033-1041. http://dx.doi.org/10.1038/sj.gt.3302487. (Pubitemid 40946145)
-
(2005)
Gene Therapy
, vol.12
, Issue.13
, pp. 1033-1041
-
-
Gentry, B.G.1
Im, M.2
Boucher, P.D.3
Ruch, R.J.4
Shewach, D.S.5
-
26
-
-
0035991948
-
Gap junctions: Structure and function
-
Review
-
Evans WH, Martin PE. 2002. Gap junctions: structure and function (Review). Mol. Membr. Biol. 19:121-136. http://dx.doi.org/10.1080/ 09687680210139839.
-
(2002)
Mol. Membr. Biol.
, vol.19
, pp. 121-136
-
-
Evans, W.H.1
Martin, P.E.2
-
27
-
-
0027452346
-
- efflux
-
Mastrocola T, Lambert IH, Kramhøft B, Rugolo M, Hoffmann EK. 1993. Volume regulation in human fibroblasts: role of Ca2 and 5-lipoxygenase products in the activation of the Cl- efflux. J. Membr. Biol. 136:55-62. (Pubitemid 23312081)
-
(1993)
Journal of Membrane Biology
, vol.136
, Issue.1
, pp. 55-62
-
-
Mastrocola, T.1
Lambert, I.H.2
Kramhoft, B.3
Rugolo, M.4
Hoffmann, E.K.5
|